DK0412766T3 - Peptidfragmenter af HIV - Google Patents

Peptidfragmenter af HIV

Info

Publication number
DK0412766T3
DK0412766T3 DK90308662.7T DK90308662T DK0412766T3 DK 0412766 T3 DK0412766 T3 DK 0412766T3 DK 90308662 T DK90308662 T DK 90308662T DK 0412766 T3 DK0412766 T3 DK 0412766T3
Authority
DK
Denmark
Prior art keywords
proline
hiv
peptide
isoleucine
fragment
Prior art date
Application number
DK90308662.7T
Other languages
English (en)
Inventor
Andrew James Mcmichael
Douglas Fraser Nixon
Alain Robert Michael Townsend
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43806939&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0412766(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Application granted granted Critical
Publication of DK0412766T3 publication Critical patent/DK0412766T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90308662.7T 1989-08-09 1990-08-07 Peptidfragmenter af HIV DK0412766T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898918200A GB8918200D0 (en) 1989-08-09 1989-08-09 The peptide fragments of hiv

Publications (1)

Publication Number Publication Date
DK0412766T3 true DK0412766T3 (da) 1994-07-18

Family

ID=43806939

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90308662.7T DK0412766T3 (da) 1989-08-09 1990-08-07 Peptidfragmenter af HIV

Country Status (12)

Country Link
US (1) US5700635A (da)
EP (1) EP0412766B1 (da)
JP (1) JPH04507100A (da)
AT (1) ATE103294T1 (da)
CA (1) CA2064691A1 (da)
DE (1) DE69007571T2 (da)
DK (1) DK0412766T3 (da)
ES (1) ES2054256T3 (da)
GB (2) GB8918200D0 (da)
HK (1) HK141494A (da)
SG (1) SG130094G (da)
WO (1) WO1991001996A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
DE346022T1 (de) * 1988-06-10 1990-05-23 Medical Research Council, London Peptidfragmente von hiv.
EP0510054A1 (en) * 1990-01-05 1992-10-28 United Biomedical, Inc. Hiv-1 core protein fragments
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
CA2173138A1 (en) * 1993-10-19 1995-04-27 Masafumi Takiguchi Peptide capable of inducing immune response against hiv and aids preventive or remedy containing the peptide
GB9426153D0 (en) * 1994-12-23 1995-02-22 Medical Res Council Improvements in or relating to vaccines
AU784679B2 (en) * 1999-12-23 2006-05-25 International Aids Vaccine Initiative Improvements in or relating to immune responses to HIV
CU23235A1 (es) 2001-02-28 2007-09-26 Ct Ingenieria Genetica Biotech POXVIRUS RECOMBINANTES PARA PROTEINAS QUIMéRICAS DEL VIRUS DE LA INMUNODEFICIENCIA HUMANA Y SU APLICACION EN LA TERAPéUTICA Y LA PREVENCION DEL SIDA
WO2009132222A2 (en) * 2008-04-24 2009-10-29 Avery Dennison Corporation Sheet having removable labels and related method
EP2620446A1 (en) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogens for HIV vaccination
CA3161633A1 (en) 2019-11-14 2021-05-20 Aelix Therapeutics, S.L. Dosage regimens for vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6713287A (en) * 1986-01-06 1987-07-09 F. Hoffmann-La Roche & Co. Expression of htlv-iii gag-gene
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection

Also Published As

Publication number Publication date
EP0412766B1 (en) 1994-03-23
ATE103294T1 (de) 1994-04-15
DE69007571D1 (de) 1994-04-28
JPH04507100A (ja) 1992-12-10
SG130094G (en) 1995-01-13
EP0412766A1 (en) 1991-02-13
WO1991001996A1 (en) 1991-02-21
US5700635A (en) 1997-12-23
GB9201468D0 (en) 1992-04-01
GB2250994B (en) 1993-08-25
DE69007571T2 (de) 1994-09-08
HK141494A (en) 1994-12-23
GB8918200D0 (en) 1989-09-20
ES2054256T3 (es) 1994-08-01
CA2064691A1 (en) 1991-02-10
GB2250994A (en) 1992-06-24

Similar Documents

Publication Publication Date Title
GB2255093A (en) Hiv-1 core protein fragments
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
DE69327587D1 (de) Konjugate von schwach immunogenen antigenen und synthetischen peptidträgern und impfstoffe diese enthaltend
ATE127345T1 (de) Stressproteine und verwendungen dafür.
DK0412766T3 (da) Peptidfragmenter af HIV
TR199801722T2 (xx) Peptit imm�nojenler.
ATE134195T1 (de) Peptidfragmente von hiv
WO1989002277A3 (en) Prophylaxis and therapy of acquired immunodeficiency syndrome
ATE185148T1 (de) Lipopeptide, t-cytotoxische lymphocyte aktivierend, und deren verwendung als vakzine
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
ES2071038T3 (es) Peptidos asociados al hiv.
DK204588D0 (da) Humane rhinoviruspeptider, fremgangsmaade til deres fremstilling samt vacciner med inhold af saadanne peptider
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
ES2061944T3 (es) Conjugado de peptido inmunologicamente activo ppd (nanp)n util como vacuna antimalaria.
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов